Kristen L. Alexander - 28 Feb 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
VP, Finance and Accounting
Signature
/s/ Kristen L. Alexander
Issuer symbol
LXRX
Transactions as of
28 Feb 2024
Net transactions value
-$30,898
Form type
4
Filing time
29 Feb 2024, 16:33:17 UTC
Previous filing
12 Feb 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +2,700 +8.9% 33,050 28 Feb 2024 Direct F1
transaction LXRX Common Stock Options Exercise +10,616 +32% 43,666 28 Feb 2024 Direct F1
transaction LXRX Common Stock Options Exercise +15,927 +36% 59,593 28 Feb 2024 Direct F1
transaction LXRX Common Stock Tax liability $30,898 -11,793 -20% $2.62 47,800 28 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -2,700 -100% 0 28 Feb 2024 Common Stock 2,700 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -10,616 -50% 10,617 28 Feb 2024 Common Stock 10,616 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -15,927 -33% 31,853 28 Feb 2024 Common Stock 15,927 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.